To view this content, you need to sign in.
You should only be asked to sign in once. Not the case? Click here
Register now to access this content and more for free.
JLL bids C$229m for drug company Patheon
The private equity firm, formerly called Joseph Littlejohn & Levy, holds a 30% stake in the Canadian company.
